Publications
Validity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study
Lix LM, Renoux C, Moriello C, Choi KL, Dormuth CR, Fisher A, Dahl M, Wu F, Asaf A, Paterson JM; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. CMAJ Open. 2023; 11(5):E790-8. Epub 2023 Sep 5.
Prescription of oxycodone versus codeine after childbirth and risk of persistent opioid use: a population-based cohort study
Zipursky JS, Everett K, Gomes T, Paterson JM, Li P, Austin PC, Mamdani M, Ray JG, Juurlink DN. CMAJ; 2023 195(29): E973-83. Epub 2023 Jul 31.
Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA. JACC Adv. 2023; May 10 [Epub ahead of print].
Up-to-date on cancer screening among Ontario patients seen by walk-in clinic physicians: a retrospective cohort study
Lofters A, Salahub C, Austin PC, Bai L, Berthelot S, Bhatia RS, Desveaux L, Ivers NM, Kiran T, Maclure M, Martin D, McBrien KA, McCracken R, Paterson JM, Rahman B, Shuldiner J, Tadrous M, Thakkar N, Lapointe-Shaw L. Prev Med. 2023; 172:107537. Epub 2023 May 6.
Modernizing Ontario’s Personal Health Information Protection Act: Recommendations for a Data-Driven Health System
Walk-in clinic patient characteristics and utilization patterns in Ontario, Canada: a cross-sectional study
Lapointe-Shaw L, Kiran T, Salahub C, Austin PC, Berthelot S, Desveaux L, Lofters A, Maclure M, Martin D, McBrien KA, McCracken RK, Rahman B, Schultz SE, Shuldiner J, Tadrous M, Bird C, Paterson JM, Bhatia RS, A Thakkar NA, Na Y, Ivers NM. CMAJ Open. 2023; 11(2):E345-56. Epub 2023 Apr 25.
Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: a multi-site population-based cohort study
Azoulay L, St-Jean A, Dahl M, Quail J, Aibibula W, Brophy JM, Chan AW, Bresee L, Carney G, Eltonsy S, Tamim H, Paterson JM, Platt RW; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. J Am Acad Dermatol. 2023; Apr 25 [Epub ahead of print].
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
Eworuke E, Shinde M, Hou L, Paterson MJ, Jensen PB, Maro JC, Rai A, Scarnecchia D, Pennap D, Woronow D, Ghosh RE, Welburn S, Pottegard A, Platt RW, Lee H, Bradley MC. BMJ Open. 2023; 13(4):e070985. Epub 2023 Apr 17.
Residual risk of breast cancer after bariatric surgery
Doumouras AG, Lovrics O, Paterson JM, Sutradhar R, Paszat L, Sivapathasundaram B, Tarride JE, Anvari M. JAMA Surg. 2023; 158(6):634-41. Epub 2023 Apr 12.